AlloCure

Sentien heads to clinic with device for renal failure

Massachusetts biotech Sentien has filed for approval to start clinical trials of a blood filtering device packed with bone marrow cells for severe cases of acute kidney injury.

Phil Taylor Apr 17, 2017 8:44am